Summary statistics of included papers
| Characteristic | No. of papers n = 13 | Author and year |
|---|---|---|
| Country | ||
| United States | 11 | Graham et al., 2020;48 Graham et al., 2021;49 Substance Abuse and Mental Health Services Administration, 2020;50 Owens et al., 2020;51 American Academy of Pediatrics, 2019;52 Hadland and Chadi, 2020;53 Gonzalvo et al., 2016;55 Berg et al., 2021;56 Sikka et al., 2021;57 Sahr et al., 2020;58 Silver et al., 201659 |
| Canada | 2 | Chadi et al., 2021;54 Health Canada, 202160 |
| Target population (age in years)* | ||
| Adolescent (10–19) | 4 | Graham et al., 2020;48 Owens et al., 2020;51 American Academy of Pediatrics, 2019;52 Chadi et al., 202154 |
| Youth (15–24) | 11 | Graham et al., 2020;48 Graham et al., 2021;49 Substance Abuse and Mental Health Services Administration, 2020;50 American Academy of Pediatrics, 2019;52 Hadland and Chadi, 2020;53 Chadi et al., 2021;54 Berg et al., 2021;56 Sikka et al., 2021;57 Sahr et al., 2020;58 Silver et al., 2016;59 Health Canada, 202160 |
| Adult (25–64) | 2 | Gonzalvo et al., 2016;55 Sikka et al., 202157 |
| Study design | ||
| RCT | 1 | Graham et al., 202149 |
| Pretest–posttest experimental study | 1 | Graham et al., 202048 |
| Guidance or recommendation | 7 | Substance Abuse and Mental Health Services Administration, 2020;50 Owens et al., 2020;51 American Academy of Pediatrics, 2019;52 Hadland and Chadi, 2020;53 Chadi et al., 2021;54 Gonzalvo et al., 2016;55 Berg et al., 202156 |
| Case report or case series | 3 | Sikka et al., 2021;57 Sahr et al., 2020;58 Silver et al., 201659 |
| Qualitative study | 1 | Health Canada, 202160 |
| Type of intervention recommended | ||
| Behavioural | 10 | Graham et al., 2020;48 Graham et al., 2021;49 Substance Abuse and Mental Health Services Administration, 2020;50 Hadland and Chadi, 2020;53 Chadi et al., 2021;54 Berg et al., 2021;56 Sikka et al., 2021;57 Sahr et al., 2020;58 Silver et al., 2016;59 Health Canada, 202160 |
| NRT | 6 | American Academy of Pediatrics, 2019;52 Hadland and Chadi, 2020;53 Chadi et al., 2021;54 Gonzalvo et al., 2016;55 Sikka et al., 2021;57 Silver et al., 201659 |
| Non-NRT | 3 | Hadland and Chadi, 2020;53 Chadi et al., 2021;54 Gonzalvo et al., 201655 |
| Based evidence on vaping cessation | ||
| Yes | 7 | Graham et al., 2020;48 Graham et al., 2021;49 Substance Abuse and Mental Health Services Administration, 2020;50 Berg et al., 2021;56 Sikka et al., 2021;57 Sahr et al., 2020;58 Silver et al., 201659 |
| No | 6 | Owens et al., 2020;51 American Academy of Pediatrics, 2019;52 Hadland and Chadi, 2020;53 Chadi et al., 2021;54 Gonzalvo et al., 2016;55 Health Canada, 202160 |
| Based on critical appraisal scores | ||
| High quality (critical appraisal scores ≥ 70%) | 10 | Graham et al., 2021;49 Substance Abuse and Mental Health Services Administration, 2020;50 Owens et al., 2020;51 American Academy of Pediatrics, 2019;52 Hadland and Chadi, 2020;53 Chadi et al., 2021;54 Berg et al., 2021;56 Sikka et al., 2021;57 Sahr et al., 2020;58 Health Canada, 202160 |
| Moderate quality (critical appraisal scores 50%–70%) | 3 | Graham et al., 2020;48 Gonzalvo et al., 2016;55 Silver et al., 201659 |
| Low quality (critical appraisal scores < 50%) | 0 | |
Note: NRT = nicotine replacement therapy, RCT = randomized controlled trial.
↵* Target population categories of adolescent and youth had overlaps with each other.